ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983

How the Institute Fared In House Markup: Chart

July 18, 1997

NIGMS Awards First Grants For Gene Mapping

August 19, 1988

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998